相关实验视频
Updated: Jul 26, 2025

07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
12.5K
黑色素瘤的克隆亚线分析揭示了异质性驱动的免疫疗法耐药机制
bioRxiv : the preprint server for biology
|June 19, 2023
概括
内异质性驱动黑色素瘤的演变,并影响对免疫检查点阻塞疗法的反应. 研究克隆亚线揭示了瘤可塑性如何影响治疗结果和免疫逃避.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 内异质性 (ITH) 复杂化癌症的进展和治疗耐药性.
- 了解ITH在免疫检查点阻塞 (ICB) 反应中的作用,对于改善疗法至关重要.
研究的目的:
- 通过使用基因多样化的小鼠黑色素瘤亚线来研究ITH对ICB反应的特定贡献.
- 分析黑色素瘤亚线的可塑性和多样性及其对瘤微环境 (TME) 和治疗反应的影响.
主要方法:
- 从异构的小鼠黑色素瘤模型 (M4) 中生成单细胞衍生克隆亚线 (M4).
- 基因组和单细胞转录组分析以表征亚系多样性和可塑性.
- 在体内瘤生长动力学的评估和与突变概况和T细胞反应的相关性.
- 与抗CTLA-4治疗反应相关的黑色素瘤分化状态和TME亚型的分析.
主要成果:
- 在M4克隆亚系中发现了显著的多样性和可塑性.
- 在体内观察到不同的瘤生长动力学,与突变特征和T细胞反应相关.
- 相关的炎症和差异化的黑色素瘤表型与积极的抗CTLA-4治疗反应.
- 证明M4亚线产生ITH,影响内在的分化和外在的TME概况,影响治疗期间的瘤进化.
结论:
- M4 克隆亚基线有效模拟 ITH,在 ICB 治疗期间影响瘤演变.
- 黑色素瘤的可塑性和瘤微环境 (TME) 形状是ICB反应的关键决定因素.
- 这些子线是研究ICB抗性机制的宝贵资源.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K

